REMIBRUTINIB TREATMENT IMPROVES HIVE SEVERITY IN PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA: PHASE 2B STUDY RESULTS

被引：0
|
作者：
Sitz, K.
Gimenez-Arnau, A.
Hayama, K.
Jain, V.
Lheritier, K.
Walsh, P.
Haemmerle, S.
Maurer, M.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2023年 / 131卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
D007
引用
收藏
页码：S11 / S11
页数：1
相关论文
共 50 条
  • [31] Efficacy and Safety of Rilzabrutinib in Patients With Chronic Spontaneous Urticaria: 12-Week Results From the RILECSU Phase 2 DoseRanging Study
    Maurer, Marcus
    Gimenez-Arnau, Ana
    Ferrucci, Silvia
    Mikol, Vincent
    Sun, Iris
    Mannent, Leda
    Gereige, Jessica
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB373 - AB373
  • [32] Ligelizumab as add-on therapy for patients with H1-antihistamine-refractory chronic spontaneous urticaria: primary results of a placebo- and active-controlled phase 2b dose-finding study
    Maurer, M.
    Gimenez-Arnau, A.
    Sussman, G.
    Loeffler, J.
    Barve, A.
    Severin, T.
    Janocha, R.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 121 - 121
  • [33] Elevated MRGPRX2 Levels Related to Disease Severity in Patients With Chronic Spontaneous Urticaria
    Cao, Thi Bich Tra
    Cha, Hyun-Young
    Yang, Eun-Mi
    Ye, Young-Min
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2021, 13 (03) : 498 - 506
  • [34] Omalizumab retreatment of patients with chronic idiopathic urticaria / chronic spontaneous urticaria following return of symptoms: primary results of the optima study
    Sussman, G.
    Hebert, J.
    Gulliver, W.
    Lynde, C. W.
    Yang, W.
    Chambenoit, O.
    Vieria, A.
    Detakacsy, F.
    Rihakova, L.
    ALLERGY, 2017, 72 : 327 - 327
  • [35] Accompanying conditions in patients with chronic spontaneous urticaria and urticarial vasculitis: Results of a retrospective study
    Akarsu, Sevgi
    Ilknur, Turna
    Ozbagcivan, Ozlem
    Fetil, Emel
    TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, 2015, 49 (01): : 18 - 24
  • [36] Time to Onset of Linaclotide Effect On the Bowel Habits in Patients with Chronic Constipation: Results from a Phase 2B Study
    Johnston, Jeffrey M.
    Lavins, Bernard J.
    MacDougall, James E.
    Lembo, Anthony J.
    Schneier, Harvey
    Shiff, Steven J.
    Kurtz, Caroline B.
    Currie, Mark G.
    GASTROENTEROLOGY, 2009, 136 (05) : A537 - A537
  • [37] Study design and rationale of a phase 3b extension study of ligelizumab in adult and adolescent patients with chronic spontaneous urticaria
    Severin, T.
    Maurer, M.
    Gimenez-Arnau, A. M.
    Hide, M.
    Sussman, G.
    Saini, S. S.
    Hua, E.
    Barve, A.
    Joubert, Y.
    Indermuehle, I.
    Janocha, R.
    ALLERGY, 2020, 75 : 446 - 447
  • [38] Omalizumab in patients with chronic spontaneous urticaria nonresponsive to H1-antihistamine treatment: results of the phase IV open-label SUNRISE study
    Berard, F.
    Le Bouedec, M. C. Ferrier
    Bouillet, L.
    Reguiai, Z.
    Barbaud, A.
    Cambazard, F.
    Milpied, B.
    Pelvet, B.
    Kasujee, I.
    Gharbi, H.
    Lacour, J. P.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 180 (01) : 56 - 66
  • [39] Patients' Experience of Parkinson's Disease Following Treatment with Inhaled Levodopa: Results from a Phase 2b Study
    LeWitt, Peter
    Niyazov, Alexander
    Sedkov, Alexander
    Murck, Harald
    Guo, Amy
    NEUROLOGY, 2016, 86
  • [40] ARS-2, Low-Dose Intranasal Epinephrine, Improves Urticaria Scores in Patients with Frequent Urticaria Flares: Phase 2 Study Results
    Bernstein, David
    Talreja, Neetu
    Casale, Thomas
    Li, H. Henry
    Shreffler, Wayne
    Lowenthal, Richard
    Tanimoto, Sarina
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB255 - AB255
12345